Molecular Partners AG
SIX:MOLN

Watchlist Manager
Molecular Partners AG Logo
Molecular Partners AG
SIX:MOLN
Watchlist
Price: 5.2 CHF 1.96% Market Closed
Market Cap: 191.6m CHF
Have any thoughts about
Molecular Partners AG?
Write Note

Molecular Partners AG
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Molecular Partners AG
Operating Income Peer Comparison

Comparables:
ADCT
ACIU
CRSP
BSLN
KURN

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Molecular Partners AG
SIX:MOLN
Operating Income
-CHf75.5m
CAGR 3-Years
-3%
CAGR 5-Years
-15%
CAGR 10-Years
N/A
ADC Therapeutics SA
NYSE:ADCT
Operating Income
-$166m
CAGR 3-Years
9%
CAGR 5-Years
-6%
CAGR 10-Years
N/A
AC Immune SA
NASDAQ:ACIU
Operating Income
-CHf60m
CAGR 3-Years
7%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
CRISPR Therapeutics AG
NASDAQ:CRSP
Operating Income
-$332.4m
CAGR 3-Years
N/A
CAGR 5-Years
-104%
CAGR 10-Years
N/A
Basilea Pharmaceutica AG
SIX:BSLN
Operating Income
-CHf8.4m
CAGR 3-Years
39%
CAGR 5-Years
13%
CAGR 10-Years
13%
Kuros Biosciences AG
SIX:KURN
Operating Income
-CHf9.2m
CAGR 3-Years
-11%
CAGR 5-Years
7%
CAGR 10-Years
N/A

See Also

What is Molecular Partners AG's Operating Income?
Operating Income
-75.5m CHF

Based on the financial report for Jun 30, 2024, Molecular Partners AG's Operating Income amounts to -75.5m CHF.

What is Molecular Partners AG's Operating Income growth rate?
Operating Income CAGR 5Y
-15%

Over the last year, the Operating Income growth was 17%. The average annual Operating Income growth rates for Molecular Partners AG have been -3% over the past three years , -15% over the past five years .

Back to Top